Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|September 1, 1994
Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infectionS L Tsai, P J Chen, L H Hwang, et al.Journal of Advanced Nursing|July 25, 2000
Priority-setting for nursing research in the Republic of ChinaT J Yin, N Hsu, S L Tsai, et al.Gastroenterology|July 13, 2000
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupY F Liaw, N W Leung, T T Chang, et al.Changgeng Yi Xue Za Zhi|June 1, 1995
[Small cell lung cancer with liver and bone metastasis associated with hypercalcemia and acute pancreatitis--a case report]T L Hsieh, J J Chen, C S Chien, et al.The Journal of Clinical Investigation|January 15, 1996
Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytesS L Tsai, M H Chen, C T Yeh, et al.Alimentary Pharmacology & Therapeutics|January 6, 2006
Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbationJ-J Chen, C-Y Lin, M-J Sheu, et al.The American Journal of Gastroenterology|January 1, 1993
Eosinophilic gastroenteritis: 10 years experienceC M Lee, C S Changchien, P C Chen, et al.Anticancer Research|August 6, 2000
Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinomaC Y Peng, S L Tsai, C T Yeh, et al.The Journal of Clinical Investigation|January 1, 1992
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversionS L Tsai, P J Chen, M Y Lai, et al.The New England Journal of Medicine|July 9, 1998
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupC L Lai, R N Chien, N W Leung, et al.Pageof 9